Australia markets open in 8 hours 36 minutes

Enzon Pharmaceuticals, Inc. (EZ1.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0515-0.0020 (-3.74%)
As of 10:05AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 5.06M
Enterprise value -39.21M
Trailing P/E 43.05
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)216.27
Price/book (mrq)1.20
Enterprise value/revenue -1.44k
Enterprise value/EBITDA 37.56

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 3-73.25%
S&P500 52-week change 321.61%
52-week high 30.2000
52-week low 30.0465
50-day moving average 30.0608
200-day moving average 30.0958

Share statistics

Avg vol (3-month) 3826
Avg vol (10-day) 32.04k
Shares outstanding 574.21M
Implied shares outstanding 694.51M
Float 830.11M
% held by insiders 110.84%
% held by institutions 148.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 430 Sept 2019
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-1.37%
Return on equity (ttm)2.99%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)98k
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)101.80%

Balance sheet

Total cash (mrq)47.01M
Total cash per share (mrq)0.63
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)27.62
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)1.3M
Levered free cash flow (ttm)-563.5k